Medication info
Lipitan Tablet 10mg (Atorvastatin Calcium Hydrate)

Lipitan Tablet 10mg (Atorvastatin Calcium Hydrate)

Prescription medicationTablet
Ingredient · strength
Atorvastatin Calcium Hydrate›10.85mg / 1 tablet
Manufacturer / importer
McNulty Pharmaceutical Co., Ltd.
Appearance
White, round, film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201501728 · Approved 2015.03.31 · Insurance code 641501710

Summary

Main use
Improvement of hyperlipidemia; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
Who uses it
Adults · Children
Adult dosage
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This drug may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg is for patients requiring an LDL cholesterol reduction of 45 % or more). This drug is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Analyze lipid levels within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and adjust the dose accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended to use LDL cholesterol levels when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, use total cholesterol levels to monitor response to treatment. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients aged 70 years or older are generally similar to those in the adult patient population.
Children's dosage
10 ~ 17 years: The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg per day (there are no clinical data on doses higher than 20 mg of this drug in pediatric patients). Adjust the dose appropriately according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer.

Ingredients

Manufacturer
McNulty Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)

  • Coronary artery disease
  • myocardial infarction
  • stroke
  • vascular surgery
  • chronic stable angina
  • retinopathy
  • albuminuria
  • hypertension
  • type 2 diabetes
  • congestive heart failure
  • angina
  • hypercholesterolemia
View approved original text

This medication helps reduce the risk of cardiovascular diseases. In particular, it can lower the risk of myocardial infarction and stroke in adults with multiple risk factors for coronary artery disease and in patients with type 2 diabetes. Additionally, patients who already have coronary artery disease are at a reduced risk of hospitalization due to myocardial infarction, stroke, angina, and congestive heart failure. This medication is also used to treat hyperlipidemia, lowering total cholesterol, LDL cholesterol, and triglyceride levels while increasing HDL cholesterol levels. It is particularly effective as an adjunct to diet in adolescents with heterozygous familial hypercholesterolemia. This medication is used to improve heart health and control blood lipid levels.

Dosage and Administration

Adult dosage

Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This drug may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg is for patients requiring an LDL cholesterol reduction of 45 % or more). This drug is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Analyze lipid levels within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and adjust the dose accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended to use LDL cholesterol levels when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, use total cholesterol levels to monitor response to treatment. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients aged 70 years or older are generally similar to those in the adult patient population.

Children's dosage

10 ~ 17 years: The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg per day (there are no clinical data on doses higher than 20 mg of this drug in pediatric patients). Adjust the dose appropriately according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer.

Precautions

This medication carries the risk of muscle abnormalities; therefore, if muscle pain or weakness becomes severe, treatment should be immediately discontinued and medical advice sought. In cases where severe muscle damage or rhabdomyolysis is suspected, medication should be stopped immediately, and extra caution is necessary for patients with impaired kidney function or hypothyroidism. This medication can affect liver function, so it should not be administered to patients with liver disease or abnormal liver enzyme levels, and regular liver function tests are necessary during treatment. Additionally, women who are pregnant or might become pregnant should not take this medication, and proper contraception must be ensured during treatment. This medication is also contraindicated for breastfeeding women and should not be used in children under 10 years of age. This medication may increase blood concentration and side effect risks when taken with specific drugs, so it is essential to inform the physician if other medications are being taken. Special caution is needed when combined with certain antibiotics, antifungals, HIV treatments, colchicine, and fibrates. Elderly patients or those with reduced kidney function should be closely monitored for muscle-related side effects. In case of overdose, there is no specific antidote, so treatment should be symptomatic, monitoring liver function and muscle enzyme levels.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • nasopharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 164 more
  • loss of appetite
  • constipation
  • abdominal bloating
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngitis
  • laryngitis
  • nosebleed
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • dysgeusia
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reaction
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased serum CK
  • positive urinary leukocytes
  • thrombocytopenia
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • increased ACTH
  • decreased aldosterone
  • elevated potassium
  • increased BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • hyperlipidemia
  • facial flushing
  • increased non-protein nitrogen
  • hyperuricemia
  • gingival hyperplasia
  • hypothermia
  • sleep disturbances
  • interstitial lung disease
  • sexual dysfunction
  • memory decline
  • forgetfulness
  • amnestic syndrome
  • memory impairment
  • confusion
  • myasthenia gravis
  • oculomotor palsy
  • vertigo
  • photosensitivity reaction
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperactivity
  • depression
  • hyperexcitability
  • myositis
  • myopathy
  • arthritis
  • bursitis
  • synovitis
  • myasthenia
  • contracture
  • increased serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcer
  • erectile dysfunction
  • urinary tract infection
  • polyuria
  • cystitis
  • hematuria
  • dysuria
  • nephrolithiasis
  • nocturia
  • epididymitis
  • breast fibrocystic changes
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical secretions
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • discoloration of urine
  • appetite stimulation
  • vasoneurogenic edema
  • chest pain
  • angina
  • facial edema
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive errors
  • eye bleeding
  • hearing loss
  • glaucoma
  • keratopathy
  • loss of taste
  • taste distortion
  • decreased testosterone
  • elevated potassium
  • increased BUN
  • cerebral infarction
  • palpitations
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it must be stored in a tightly closed container. The storage temperature should be kept at room temperature between 1 degree and 30 degrees Celsius. This helps maintain the medication's effectiveness over time.

Appearance and packaging

Appearance

White, round, film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.